Kampmann H
Arch Geschwulstforsch. 1975;45(4):313-23.
For the first time results of investigations on rats with radioactive compounds in autochtonal tumors of the central nervous system, induced via placenta by Ethyl-Nitrose-Urea (ENU), are reported. In contrast to transplantation tumors the tumors induced by ENU are comparable in regard to the szintigrafic results with human brain tumors. The radiopharmaceuticals 131I-HSA, 99mTc-Pertechnetate, 203Hg-Chlormerodrin and 113m/111In-DTPA are similar to human brain tumors taken up by the ENU-tumors. For these findings it may be important, that the ENU-tumors are of neurogenic origin and do not differ histologically from the human brain tumors. The accumulation of the radioactive substances in ENU-tumors can be explained with the lesion at the blood-brain-barrier and at the blood-nerv-barrier. Therefore, it is discussed that the mechanism of the uptake is similar in human brain neoplasms and in ENU-tumors of the brain. The ENU-tumor model is suitable for testing new radiopharmaceuticals before their application in men.
首次报道了对经胎盘由乙基-亚硝基脲(ENU)诱导产生中枢神经系统自发性肿瘤的大鼠进行放射性化合物研究的结果。与移植性肿瘤不同,ENU诱导的肿瘤在闪烁扫描结果方面与人脑肿瘤具有可比性。放射性药物131I-人血清白蛋白、99m锝-高锝酸盐、203汞-氯汞君和113m/111铟-二乙三胺五乙酸被ENU肿瘤摄取的情况与人脑肿瘤相似。对于这些发现,可能重要的是ENU肿瘤起源于神经源性,并且在组织学上与人脑肿瘤没有差异。放射性物质在ENU肿瘤中的积累可以用血脑屏障和血神经屏障的损伤来解释。因此,有人讨论,人脑肿瘤和脑ENU肿瘤的摄取机制相似。ENU肿瘤模型适用于在新放射性药物应用于人体之前进行测试。